The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
5.26
+0.01 (0.19%)
At close: Jun 18, 2026, 4:00 PM EDT
5.24
-0.02 (-0.38%)
After-hours: Jun 18, 2026, 7:11 PM EDT

The Oncology Institute Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
52642123151121874
Market Cap Growth
84.18%1698.25%-84.53%25.12%-86.16%834.75%
Enterprise Value
600.54490.9696.89188.08155.26758.61
Last Close Price
5.263.560.312.041.659.75
PS Ratio
0.960.840.060.470.484.30
PB Ratio
--26.776.522.650.988.39
P/TBV Ratio
---4.721.5910.89
EV/Sales Ratio
1.100.980.250.580.613.74
Debt / Equity Ratio
-5.98-6.1432.421.990.830
Net Debt / Equity Ratio
-4.58-4.4620.480.650.28-1.10
Net Debt / EBITDA Ratio
-2.88-2.41-1.36-0.52-0.442.71
Net Debt / FCF Ratio
-2.90-2.52-2.42-0.90-0.513.24
Asset Turnover
3.282.982.061.381.091.51
Inventory Turnover
22.5331.6828.6223.0825.5330.05
Quick Ratio
1.131.311.883.623.844.58
Current Ratio
1.471.592.154.124.395.17
Return on Equity (ROE)
271.91%999.19%-213.36%-92.20%0.13%-16.52%
Return on Assets (ROA)
-19.58%-21.44%-31.48%-32.72%58.86%-36.05%
Return on Invested Capital (ROIC)
-48.90%-49.91%-68.47%-58.91%123.16%-97.03%
Return on Capital Employed (ROCE)
-35.80%-33.69%-40.76%-37.90%-40.41%-43.52%
Buyback Yield / Dilution
-30.10%-23.11%-1.76%8.51%-21.70%-12.03%
Total Shareholder Return
-30.10%-23.11%-1.76%8.51%-21.70%-12.03%
SEC Filings: 10-K · 10-Q